The article focuses on attorney Andrew Waldron, head of legal at the drug development company Cancer Research Technology (CRT). Topics include his experience working at the law firm Hill Dickinson, his thoughts on the differences between private practice and corporate law, and his work with pharmaceutical companies.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados